ADENOSCAN adenosine 30mg/10mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

adenoscan adenosine 30mg/10ml injection vial

sanofi-aventis australia pty ltd - adenosine, quantity: 30 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - intravenous adenoscan is a coronary vasodilator for use in conjunction with radionuclide myocardial perfusion imaging, in patients unable to exercise adequately.

ADENOCOR Adenosine 6mg/2mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

adenocor adenosine 6mg/2ml injection

sanofi-aventis australia pty ltd - adenosine, quantity: 3 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - therapeutic indications: rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory by-pass tracts (wolff-parkinson-white syndrome). diagnostic indications: aid to diagnosis of broad or narrow complex supraventricular tachycardias. although adenocor is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. in this respect adenosine should be used as an adjunct to, but not a replacement for, clinical and ecg observations. it should be only used when, despite all diagnostic attempts, doubt still persists. improved diagnostic sensitivity of intracavity electrophysiological investigations

ADSINE adenosine 6 mg/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

adsine adenosine 6 mg/2 ml solution for injection vial

baxter healthcare pty ltd - adenosine, quantity: 6 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - adenosine 6 mg/2 ml:,therapeutic indications rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white syndrome). diagnostic indications aid to diagnosis of broad or narrow qrs complex supraventricular tachycardias. although adenosine 6 mg/2 ml is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. in this respect adenosine should be used as an adjunct to, but not a replacement for, clinical and ecg observations. it should be used only when, despite all diagnostic attempts, doubt still persists. improved diagnostic sensitivity of intracavity electrophysiological investigations.

ADENOSINE BAXTER adenosine 30 mg/10 mL solution for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

adenosine baxter adenosine 30 mg/10 ml solution for infusion vial

baxter healthcare pty ltd - adenosine, quantity: 30 mg - solution - excipient ingredients: sodium chloride; water for injections - intravenous adenosine (30 mg/10 ml) is a coronary vasodilator for use in conjunction with radionuclide myocardial perfusion imaging, in patients unable to exercise adequately.